Molecular Medicine

, Volume 9, Issue 3–4, pp 85–95 | Cite as

Profiling of Hodgkin’s Lymphoma Cell Line L1236 and Germinal Center B Cells: Identification of Hodgkin’s Lymphoma-specific Genes

  • Ines Schwering
  • Andreas Bräuninger
  • Verena Distler
  • Julia Jesdinsky
  • Volker Diehl
  • Martin-Leo Hansmann
  • Klaus Rajewsky
  • Ralf Küppers


The malignant cells of classical Hodgkin’s lymphoma (cHL), Hodgkin and Reed-Sternberg (HRS) cells, appear to be derived from germinal center (GC) B cells in most cases of the disease. Apart from recent findings of constitutive activation of some transcription factors and autocrine stimulation by cytokine receptors, the mechanisms of malignant transformation in cHL still remain poorly understood. We performed a large scale gene expression study using serial analysis of gene expression (SAGE), comparing the cHL cell line L1236 and human GC B cells. Semiquantitative RT-PCR was used to confirm results from the SAGE and to analyze gene expression in 3 additional cHL cell lines. To investigate expression of some genes in cHL cases, we applied RT-PCR on microdissected HRS cells. In total, 464 genes showed a change in expression level of 5-fold or higher. For 12 genes (out of 177) identified as upregulated in L1236 cells, RT-PCR confirmed the SAGE results and also showed elevated expression in 3 other cHL cell lines. For 3 of the upregulated genes, expression by HRS cells in the tissue also was confirmed. Several of the differentially expressed genes may play a role in the pathogenesis of cHL because they represent potential oncogenes, such as rhoC, L-myc, and PTP4A, or transcription factors, such as ATF-5, ATBF1, and p21SNFT. The genes that showed significantly deregulated expression in HRS cells should be helpful not only for the identification of genes involved in the pathogenesis of cHL but also for discovering potential prognostic markers or therapeutic targets.



This work was supported through the Deutsche Forschungsgemeinschaft by SFB502 and a Heisenberg award to RK. We are grateful to Yvonne Blum, Michaela Fahrig, Christine Gerhardt, and Tanja Schaffer for excellent technical assistance, to Berit Jungnickel for stimulating discussions, and to Carel van Noesel for critically reading this manuscript.


  1. 1.
    Drexler HG. (1992) Recent results on the biology of Hodgkin and Reed-Sternberg cells. I. biopsy material. Leuk. Lymphoma 8:283–313.CrossRefGoogle Scholar
  2. 2.
    Pinkus GS et al. (1997) Fascin, a sensitive new marker for Reed-Sternberg cells of Hodgkin’s disease. Evidence for a dendritic or B cell derivation? Am. J. Pathol. 150:543–62.PubMedPubMedCentralGoogle Scholar
  3. 3.
    van den Berg A, Visser L, Poppema S. (1999) High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltration Hodgkin’s lymphoma. Am. J. Pathol. 154:1685–91.CrossRefGoogle Scholar
  4. 4.
    Küppers R. (2002) Molecular biology of Hodgkin’s lymphoma. Adv. Cancer Res. 84:277–312.CrossRefGoogle Scholar
  5. 5.
    Stein H et al. (2001) Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood 97:496–501.CrossRefGoogle Scholar
  6. 6.
  7. 7.
    Schwering I et al. (2003) Loss of the B lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin’s lymphoma. Blood 101:1505–12.CrossRefGoogle Scholar
  8. 8.
    Kanzler H, Küppers R, Hansmann ML, Rajewsky K. (1996) Hodgkin and Reed-Sternberg cells in Hodgkin’s disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J. Exp. Med. 184:1495–505.CrossRefGoogle Scholar
  9. 9.
    Marafioti T et al. (2000) Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 95:1443–50.PubMedGoogle Scholar
  10. 10.
    Bräuninger A et al. (1999) Identification of common germinal-center B-cell precursors in 2 patients with both Hodgkin’s disease and Non-Hodgkin’s lymphoma. N. Engl. J. Med. 340:1239–47.CrossRefGoogle Scholar
  11. 11.
    Küppers R et al. (2001) Common germinal-center B-cell origin of the malignant cells in two composite lymphomas, involving classical Hodgkin’s disease and either follicular lymphoma or B-CLL. Mol. Med. 7:285–92.CrossRefGoogle Scholar
  12. 12.
    Marafioti T et al. (1999) Classical Hodgkin’s disease and follicular lymphoma originating from the same germinal center B cell. J. Clin. Oncol. 17:3804–9.CrossRefGoogle Scholar
  13. 13.
    Irsch J et al. (2001) Class switch recombination was specifically targeted to immunoglobulin (Ig)G4 or IgA in Hodgkin’s disease-derived cell lines. Br. J. Haematol. 113:785–93.CrossRefGoogle Scholar
  14. 14.
    Müschen M et al. (2000) Rare occurrence of classical Hodgkin’s disease as a T cell lymphoma. J. Exp. Med. 191:387–94.CrossRefGoogle Scholar
  15. 15.
    Seitz V et al. (2000) Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease. Blood 95:3020–4.PubMedGoogle Scholar
  16. 16.
    Cossman J et al. (1999) Reed-Sternberg cell genome expression supports a B-cell lineage. Blood 94:411–6.PubMedGoogle Scholar
  17. 17.
    Nacht M et al. (2001) Molecular characteristics of non-small cell lung cancer. Proc. Natl. Acad. Sci. U.S.A. 98:15203–8.CrossRefGoogle Scholar
  18. 18.
    Zhang L et al. (1997) Gene expression profiles in normal and cancer cells. Science 276:1268–72.CrossRefGoogle Scholar
  19. 19.
    Wolf J et al. (1996) Peripheral blood mononuclear cells of a patient with advanced Hodgkin’s lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells. Blood 87:3418–28.PubMedGoogle Scholar
  20. 20.
    Kanzler H et al. (1996) Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin/Reed-Sternberg cells of a Hodgkin’s lymphoma patient. Blood 87:3429–36.PubMedGoogle Scholar
  21. 21.
    Hopken UE et al. (2002) Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs. Blood 99:1109–16.CrossRefGoogle Scholar
  22. 22.
    Kapp U et al. (1999) Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J. Exp. Med. 189:1939–46.CrossRefGoogle Scholar
  23. 23.
    Bargou RC et al. (1997) Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin’s disease tumor cells. J. Clin. Invest. 100:2961–9.CrossRefGoogle Scholar
  24. 24.
    Drexler HG. (1993) Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. continuous cell lines. Leuk. Lymphoma 9:1–25.CrossRefGoogle Scholar
  25. 25.
    Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. (1995) Serial analysis of gene expression. Science 270:484–7.CrossRefGoogle Scholar
  26. 26.
    Klein U et al. (2003) Transcriptional analysis of the B-cell germinal center reaction. Proc. Natl. Acad. Sci. U.S.A. 100:2639–44.CrossRefGoogle Scholar
  27. 27.
    Pascual V et al. (1994) Analysis of somatic mutation in five B cell subsets of human tonsil. J. Exp. Med. 180:329–39.CrossRefGoogle Scholar
  28. 28.
    Oka K, Mori N, Haimoto H, Kato K. (1990) Expression of enolases in T cell tumors and Hodgkin’s disease. Lab. Invest. 63:792–7.PubMedGoogle Scholar
  29. 29.
    Messineo C et al. (1998) Gene expression by single Reed-Sternberg cells: pathways of apoptosis and activation. Blood 91:2443–51.PubMedGoogle Scholar
  30. 30.
    Anwar F, Wood BL. (2000) CD44H and CD44V6 expression in different subtypes of Hodgkin lymphoma. Mod. Pathol. 13:1121–7.CrossRefGoogle Scholar
  31. 31.
    Johnson EN, Druey KM. (2002) Functional characterization of the G protein regulator RGS13. J. Biol. Chem. 277:16768–74.CrossRefGoogle Scholar
  32. 32.
    Zhou J et al. (2001) Characterization of RGS5 in regulation of G protein-coupled receptor signaling. Life Sci. 68:1457–69.CrossRefGoogle Scholar
  33. 33.
    Spain BH et al. (1996) Two human cDNAs, including a homolog of Arabidopsis FUS6 (COP11), suppress G-protein- and mitogen-activated protein kinase-mediated signal transduction in yeast and mammalian cells. Mol. Cell Biol. 16:6698–706.CrossRefGoogle Scholar
  34. 34.
    Bachner D, Sedlacek Z, Korn B, Hameister H, Poustka A. (1995) Expression patterns of two human genes coding for different rab GDP-dissociation inhibitors (GDIs), extremely conserved proteins involved in cellular transport. Hum. Mol. Genet. 4:701–8.CrossRefGoogle Scholar
  35. 35.
    Scherle P, Behrens T, Staudt LM. (1993) Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 90:7568–72.CrossRefGoogle Scholar
  36. 36.
    Saha S et al. (2001) A phosphatase associated with metastasis of colorectal cancer. Science 294:1343–6.CrossRefGoogle Scholar
  37. 37.
    Clark EA, Golub TR, Lander ES, Hynes RO. (2000) Genomic analysis of metastasis reveals an essential role for rhoC. Nature 406:532–5.CrossRefGoogle Scholar
  38. 38.
    Barrett J, Birrer MJ, Kato GJ, Dosaka-Akita H, Dang CV. (1992) Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells. Mol. Cell Biol. 12:3130–7.CrossRefGoogle Scholar
  39. 39.
    Lah TT, Kos J. (1998) Cysteine proteinases in cancer progression and their clinical relevance for prognosis. Biol. Chem. 379:125–30.PubMedGoogle Scholar
  40. 40.
    Menard S, Tagliabue E, Colnaghi MI. (1998) The 67 kDa laminin receptor as a prognostic factor in human cancer. Breast Cancer Res. Treat. 52:137–45.CrossRefGoogle Scholar
  41. 41.
    Goodison S, Urquidi V, Tarin D. (1999) CD44 cell adhesion molecules. Mol. Pathol. 52:189–196.CrossRefGoogle Scholar
  42. 42.
    Boutros M, Mlodzik M. (1999) Dishevelled: at the crossroads of divergent intracellular signaling pathways. Mech. Dev. 83:27–37.CrossRefGoogle Scholar
  43. 43.
    Aryee DN et al. (1996) Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumour aggressiveness. Br. J. Cancer 74:1693–8.CrossRefGoogle Scholar
  44. 44.
    Ikeda H et al. (1997) Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6:199–208.CrossRefGoogle Scholar
  45. 45.
    Iacobelli M, Wachsman W, McGuire KL. (2000) Repression of IL-2 promoter activity by the novel basic leucine zipper p21SNFT protein. J. Immunol. 165:860–8.CrossRefGoogle Scholar
  46. 46.
    Peters CS et al. (2001) ATF-7, a novel bZIP protein, interacts with the PRL-1 protein-tyrosine phosphatase. J. Biol. Chem. 276:13718–26.CrossRefGoogle Scholar
  47. 47.
    Morinaga T, Yasuda H, Hashimoto T, Higashio K, Tamaoki T. (1991) A human alpha-fetoprotein enhancer-binding protein, ATBF1, contains 4 homeodomains and seventeen zinc fingers. Mol. Cell Biol. 11:6041–9.CrossRefGoogle Scholar
  48. 48.
    Li X, Commane M, Jiang Z, Stark GR. (2001) IL-1-induced NFκ B and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK). Proc. Natl. Acad. Sci. U.S.A. 98:4461–5.CrossRefGoogle Scholar
  49. 49.
    Bolin LM et al. (1997) HNMP-1: a novel hematopoietic and neural membrane protein differentially regulated in neural development and injury. J. Neurosci. 17:5493–502.CrossRefGoogle Scholar
  50. 50.
    Guzman-Rojas L et al. (2000) PRELI, the human homologue of the avian px19, is expressed by germinal center B lymphocytes. Int. Immunol. 12:607–12.CrossRefGoogle Scholar
  51. 51.
    Peattie DA et al. (1992) Expression and characterization of human FKBP52, an immunophilin that associates with the 90-kDa heat shock protein and is a component of steroid receptor complexes. Proc. Natl. Acad. Sci. U.S.A 89:10974–8.CrossRefGoogle Scholar
  52. 52.
    Shaulian E, Karin M. (2001) AP-1 in cell proliferation and survival. Oncogene 20:2390–2400.CrossRefGoogle Scholar
  53. 53.
    Küppers R et al. (2003) Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J.Clin. Invest. 111:529–37.CrossRefGoogle Scholar
  54. 54.
    Jox A et al. (1999) Somatic mutations within the untranslated regions of rearranged Ig genes in a case of classical Hodgkin’s disease as a potential cause for the absence of Ig in the lymphoma cells. Blood 93:3964–72.PubMedGoogle Scholar
  55. 55.
    Buckbinder L et al. (1997) The p53 tumor suppressor targets a novel regulator of G protein signaling. Proc. Natl. Acad. Sci. U.S.A. 94:7868–72.CrossRefGoogle Scholar
  56. 56.
    Aron B, Hall A. (2002) Rho GTPases in Transformation and Metastasis. Adv. Cancer Res. 84:57–80.CrossRefGoogle Scholar
  57. 57.
    Cates CA et al. (1996) Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases. Cancer Lett. 110:49–55.CrossRefGoogle Scholar
  58. 58.
    Diamond RH, Cressman DE, Laz TM, Abrams CS, Taub R. (1994) PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth. Mol. Cell Biol. 14:3752–62.CrossRefGoogle Scholar
  59. 59.
    Kaspar P et al. (1999) Myb-interacting protein, ATBF1, represses transcriptional activity of Myb oncoprotein. J. Biol. Chem. 274:14422–8.CrossRefGoogle Scholar
  60. 60.
    Berry FB et al. (2001) Positive and negative regulation of myogenic differentiation of C2C12 cells by isoforms of the multiple homeodomain zinc finger transcription factor ATBF1. J. Biol. Chem. 276:25057–65.CrossRefGoogle Scholar
  61. 61.
    Miura Y et al. (1995) Cloning and characterization of an ATBF1 isoform that expresses in a neuronal differentiation-dependent manner. J. Biol. Chem. 270:26840–8.CrossRefGoogle Scholar
  62. 62.
    Mathas S et al. (2002) Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-κB. EMBO J. 21:4104–13.CrossRefGoogle Scholar

Copyright information

© Feinstein Institute for Medical Research 2003

Authors and Affiliations

  • Ines Schwering
    • 1
    • 2
  • Andreas Bräuninger
    • 3
  • Verena Distler
    • 3
  • Julia Jesdinsky
    • 2
  • Volker Diehl
    • 2
  • Martin-Leo Hansmann
    • 3
  • Klaus Rajewsky
    • 1
  • Ralf Küppers
    • 1
    • 2
  1. 1.Institute for GeneticsUniversity of CologneCologneGermany
  2. 2.Department of Internal Medicine I, LFI, E4, R706University of CologneCologneGermany
  3. 3.Department of PathologyUniversity of FrankfurtFrankfurt/MainGermany

Personalised recommendations